Adolescents and Young Adults with Mental Health Disorders at Risk of Long-Term Opioid Use

Patients ages 13 to 24 given opioids for pain more than twice as likely to become addicted if they have mental health disorder, study finds


Long-term use and abuse of opioid painkillers, such as OxyContin and Vicodin, has markedly increased in the United States in the last two decades. Of note, prescription opioids constitute 86.9 percent of prescription drug misuse among high school students. And last week in a two-day U.S. Food and Drug Administration public meeting, officials questioned the use of long-term opioids for chronic pain due to a lack of evidence for the effectiveness and concerns about the potential risk for addiction.

While previous studies have shown that depression and substance abuse peaks during adolescence and young adulthood, studies assessing the link between mental health issues and opioid use in this population were lacking.

Laura Richardson, MD, and a team at the Seattle Children’s Research Institute and the University of Washington conducted a longitudinal study to examine the association between mental health disorders and subsequent risk for long-term opioid use among adolescents and young adults ages 13 to 24. They found that those with mental health disorders were not only more likely to be prescribed opioids for chronic pain but also 2.4 times more likely to become long-term opioid users than those who didn’t have a mental health disorder. The study also found that long-term opioid use was more common among males, older youth and youth who lived in communities that were poorer, had more white residents, and had fewer residents who had attended college.

Mental Health Disorders and Long-term Opioid Use Among Adolescents and Young Adults With Chronic Pain,” was published in the June 2012 Journal of Adolescent Health. The study’s data set contains information from January 2001 to June 2008, and tracked opioid usage patterns of 62,560 adolescent and young adults from the West, Midwest and Southwest regions of the United States. Long-term opioid use is defined as using opioids for more than 90 days within a six-month period with no gap of usage over 30 days. Chronic pain complaints included back pain, neck pain, headache and arthritis or joint pain.

“There are a number of reasons why adolescents and young adults with mental health issues are more likely to become long-term users of opioids,” said Dr. Richardson, who is also an associate professor of pediatrics at the University of Washington. “Depression and anxiety might increase pain symptoms and lead to longer treatment, and physicians may see depressed patients as being more distressed and may be willing to treat pain symptoms over a longer period of time.”

While there may be a role for opioids in treating some patients, Dr. Richardson offers the following tips aimed to help reduce risk of long-term opioid use for parents, patients and medical professionals:

  • Providers should have frank conversations with families about the long-term use of opioids and the risks involved.
  • Providers should screen for mental health disorders before starting medications, and should consider referring patients with depression or anxiety for counseling or other mental health treatment.
  • Parents and patients should ask how long the provider anticipates that the patient will be treated with opioids. For most conditions, such as post-surgical pain or dental procedures, the treatment should be no longer than two weeks.
  • Parents who are concerned that adolescents might have depression or anxiety should advocate for them to make sure they get the help and treatment they need.
  • Parents and patients should appropriately discard any unused opioid prescriptions, and take advantage of “take back your drugs” days and drop sites at local police stations and pharmacies.

Dr. Richardson shares these tips, and more, in a video: http://youtu.be/Rxv1707oX0c.

Dr. Richardson’s co-authors were: Joan Russo, PhD, University of Washington; Wayne Katon, MD, University of Washington; Carolyn McCarty, PhD, Seattle Children’s Research Institute, University of Washington; Andrea DeVries, PhD, HealthCore Inc.; Mark Edlund, MD, PhD, University of Arkansas for Medical Sciences; Bradley Martin, PharmD, PhD, University of Arkansas for Medical Sciences; and Mark Sullivan, MD, PhD, University of Washington.

This study was supported by grants from the Alcohol and Drug Abuse Institute at the University of Washington and from the National Institute on Drug Abuse.

Supporting Materials:

About Seattle Children’s

Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.

Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation's top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research.

For more information, visit seattlechildrens.org or follow us on Twitter, Facebook, Instagram or on our On the Pulse blog.